Associated Papers
A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review.
Li D et al.
Oncotargets and Therapy, 2023
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis.
Talvitie EM et al.
Neoplasia (new York, N.y.), 2022
Epidermal Growth Factor Receptor Mutation Frequency in Squamous Cell Carcinoma and Its Diagnostic Performance in Cytological Samples: A Molecular and Immunohistochemical Study.
Kumari N et al.
World Journal of Oncology, 2019
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.
Siegele BJ et al.
Lung Cancer (amsterdam, Netherlands), 2016
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
Cardnell RJ et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2015
Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients.
Bichev SN et al.
Cellular Oncology (dordrecht, Netherlands), 2015
Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
Villa C et al.
Archives of Pathology & Laboratory Medicine, 2014
Clinical predictors of response to EGFR tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer.
Fukihara J et al.
Oncology, 2014
The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.
Shanzhi W et al.
Plos One, 2014
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice.
Gahr S et al.
British Journal of Cancer, 2013
Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
Liu Y et al.
International Journal of Clinical and Experimental Pathology, 2013
Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.
Santis G et al.
Plos One, 2011
[Molecular profiling of non-small cell lung cancer].
Gibault L et al.
Revue De Pneumologie Clinique, 0
Select a paper to view details